Skip to main content
Top
Published in: Infection 1/2014

01-02-2014 | Clinical and Epidemiological Study

Trauma is associated with a better prognosis in intensive care patients with Acinetobacter infections

Authors: A. C. Tonacio, M. S. Oliveira, L. M. S. Malbouisson, A. S. Levin

Published in: Infection | Issue 1/2014

Login to get access

Abstract

Purpose

Acinetobacter baumannii has emerged as a common cause of infection in war-related trauma, civilian trauma and other surgical emergencies. The aim of this study was to determine prognostic factors especially trauma, in critically ill surgical patients with Acinetobacter spp. infection in a reference emergency ICU.

Methods

A retrospective review of medical records was conducted for all patients admitted to the ICU who developed Acinetobacter spp. infection from January 2007 to December 2009. Bivariate and multivariate analyses were made for 36 patients. The end-point analyzed was the in-hospital mortality.

Results

The initial analysis revealed a majority of young (43.6 years ± 17.1) men (92 %), trauma victims (78 %) and an in-hospital mortality of 30 %. Patients who had not suffered trauma presented with other surgical conditions and were on average older than trauma patients (57 ± 12 versus 40 ± 16 years). The overall APACHE II score average was 15.3. The ventilator-associated pneumonia was the main Acinetobacter infection diagnosed. In bivariate analysis lower Glasgow coma scale (p = 0.01) was associated with increased chance of death and being victim of trauma was a protecting factor (OR: 0.16; 95 % CI: 0.03–0.89). Receiving adequate treatment made no difference to outcome (OR: 0.55; 95 % CI: 0.05–3.15). Multivariate analysis showed that only the presence of trauma was independently associated with prognosis and was a protecting factor.

Conclusion

Trauma was a marker of good prognosis in emergency ICU patients with Acinetobacter spp. infection.
Literature
1.
go back to reference Falagas ME, Bliziotis IA, Siempos II. Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies. Crit Care. 2006;10:R48.PubMedCrossRef Falagas ME, Bliziotis IA, Siempos II. Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies. Crit Care. 2006;10:R48.PubMedCrossRef
2.
go back to reference Garcia-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J, Jimenez-Jimenez FJ, Monterrubio-Villar J, Gili-Miner M. Mortality and the increase in length of stay attributable to the acquisi-tion of Acinetobacter in critically ill patients. Crit Care Med. 1999;27:1794–9.PubMedCrossRef Garcia-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J, Jimenez-Jimenez FJ, Monterrubio-Villar J, Gili-Miner M. Mortality and the increase in length of stay attributable to the acquisi-tion of Acinetobacter in critically ill patients. Crit Care Med. 1999;27:1794–9.PubMedCrossRef
3.
go back to reference Lortholary O, Fagon JY, Hoi AB, Slama MA, Pierre J, Giral P, Rosenzweig R, Gutmann L, Safar M, Acar J. Nosocomial acquisition of multiresistant Acinetobacter baumannii: risk factors and prognosis. Clin Infect Dis. 1995;20:790–6.PubMedCrossRef Lortholary O, Fagon JY, Hoi AB, Slama MA, Pierre J, Giral P, Rosenzweig R, Gutmann L, Safar M, Acar J. Nosocomial acquisition of multiresistant Acinetobacter baumannii: risk factors and prognosis. Clin Infect Dis. 1995;20:790–6.PubMedCrossRef
4.
go back to reference Blot S, Vandewoude K, Colardyn F. Nosocomial bacteremia involving Acinetobacter spp. in critically ill patients: a matched cohort study. Intensive Care Med. 2003;29:471–5.PubMed Blot S, Vandewoude K, Colardyn F. Nosocomial bacteremia involving Acinetobacter spp. in critically ill patients: a matched cohort study. Intensive Care Med. 2003;29:471–5.PubMed
5.
go back to reference Weingarten CM, Rybak MJ, Jahns BE, Stevenson JG, Brown WJ, Levine DP. Evaluation of Acinetobacter baumannii infection and colonization, and antimicrobial treatment patterns in an urban teaching hospital. Pharmacotherapy. 1999;19:1080–5.PubMedCrossRef Weingarten CM, Rybak MJ, Jahns BE, Stevenson JG, Brown WJ, Levine DP. Evaluation of Acinetobacter baumannii infection and colonization, and antimicrobial treatment patterns in an urban teaching hospital. Pharmacotherapy. 1999;19:1080–5.PubMedCrossRef
6.
go back to reference Trottier V, Namias N, Pust DG, Nuwayhid Z, Manning R, Marttos AC Jr, Dunham MB, Schulman CI, McKenney MG. Outcomes of Acinetobacter baumannii infection in critically ill surgical patients. Surg Infect (Larchmt). 2007;8:437–43.CrossRef Trottier V, Namias N, Pust DG, Nuwayhid Z, Manning R, Marttos AC Jr, Dunham MB, Schulman CI, McKenney MG. Outcomes of Acinetobacter baumannii infection in critically ill surgical patients. Surg Infect (Larchmt). 2007;8:437–43.CrossRef
7.
go back to reference Jang TN, Lee SH, Huang CH, Lee CL, Chen WY. Risk factors and impact of nosocomial Acinetobacter spp. bloodstream infections in the adult intensive care unit: a case-control study. J Hosp Infect. 2009;73:143–50.PubMedCrossRef Jang TN, Lee SH, Huang CH, Lee CL, Chen WY. Risk factors and impact of nosocomial Acinetobacter spp. bloodstream infections in the adult intensive care unit: a case-control study. J Hosp Infect. 2009;73:143–50.PubMedCrossRef
8.
go back to reference Sebeny PJ, Riddle MS, Petersen K. Acinetobacter spp. skin and soft-tissue infection associated with war trauma. Clin Infect Dis. 2008;47:444–9.PubMedCrossRef Sebeny PJ, Riddle MS, Petersen K. Acinetobacter spp. skin and soft-tissue infection associated with war trauma. Clin Infect Dis. 2008;47:444–9.PubMedCrossRef
9.
go back to reference Caricato A, Montini L, Bello G, Michetti V, Maviglia R, Bocci MG, Mercurio G, Maggiore SM, Antonelli M. Risk factors and outcome of Acinetobacter baumannii infection in severe trauma patients. Intensive Care Med. 2009;35:1964–9.PubMedCrossRef Caricato A, Montini L, Bello G, Michetti V, Maviglia R, Bocci MG, Mercurio G, Maggiore SM, Antonelli M. Risk factors and outcome of Acinetobacter baumannii infection in severe trauma patients. Intensive Care Med. 2009;35:1964–9.PubMedCrossRef
10.
go back to reference Kang G, Hartzell JD, Howard R, Wood-Morris RN, Johnson MD, Fraser S, Weintrob A, Wortmann G. Mortality associated with Acinetobacter spp. complex bacteremia among patients with war-related trauma. Infect Control Hosp Epidemiol. 2010;31:92–4.PubMedCrossRef Kang G, Hartzell JD, Howard R, Wood-Morris RN, Johnson MD, Fraser S, Weintrob A, Wortmann G. Mortality associated with Acinetobacter spp. complex bacteremia among patients with war-related trauma. Infect Control Hosp Epidemiol. 2010;31:92–4.PubMedCrossRef
11.
go back to reference Eberle BM, Schnüriger B, Putty B, Barmparas G, Kobayashi L, Inaba K, Belzberg H, Demetriades D. The impact of Acinetobacter baumannii infections on outcome in trauma patients: a matched cohort study. Crit Care Med. 2010;38:2133–8.PubMedCrossRef Eberle BM, Schnüriger B, Putty B, Barmparas G, Kobayashi L, Inaba K, Belzberg H, Demetriades D. The impact of Acinetobacter baumannii infections on outcome in trauma patients: a matched cohort study. Crit Care Med. 2010;38:2133–8.PubMedCrossRef
12.
go back to reference Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309–32.PubMedCrossRef Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309–32.PubMedCrossRef
13.
go back to reference Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818–29.PubMedCrossRef Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818–29.PubMedCrossRef
14.
go back to reference Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;2:81–4.PubMedCrossRef Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;2:81–4.PubMedCrossRef
15.
go back to reference Erbay A, Idil A, Gozel MG, Mumcuoglu I, Balaban N. Impact of early appropriate antimicrobial therapy on survival in Acinetobacter baumannii bloodstream infections. Int J Antimicrob Agents. 2009;34:575–9.PubMedCrossRef Erbay A, Idil A, Gozel MG, Mumcuoglu I, Balaban N. Impact of early appropriate antimicrobial therapy on survival in Acinetobacter baumannii bloodstream infections. Int J Antimicrob Agents. 2009;34:575–9.PubMedCrossRef
16.
go back to reference Tuon FF, Rymsza AM, Penteado-Filho SR, Pilonetto M, Arend LN, Levin AS. Should polymyxin be used empirically to treat infections in patients under high risk for carbapenem-resistant Acinetobacter? J Infect. 2011;62:246–9.PubMedCrossRef Tuon FF, Rymsza AM, Penteado-Filho SR, Pilonetto M, Arend LN, Levin AS. Should polymyxin be used empirically to treat infections in patients under high risk for carbapenem-resistant Acinetobacter? J Infect. 2011;62:246–9.PubMedCrossRef
17.
go back to reference Breslow JM, Monroy MA, Daly JM, Meissler JJ, Gaughan J, Adler MW, Eisenstein TK. Morphine, but not trauma, sensitizes to systemic Acinetobacter baumannii infection. J Neuroimmune Pharmacol. 2011;6:551–65.PubMedCrossRef Breslow JM, Monroy MA, Daly JM, Meissler JJ, Gaughan J, Adler MW, Eisenstein TK. Morphine, but not trauma, sensitizes to systemic Acinetobacter baumannii infection. J Neuroimmune Pharmacol. 2011;6:551–65.PubMedCrossRef
18.
go back to reference Howard A, O’Donoghue M, Feeney A, Sleator RD. Acinetobacter baumannii—an emerging opportunistic pathogen. Virulence. 2012;3:1–8.CrossRef Howard A, O’Donoghue M, Feeney A, Sleator RD. Acinetobacter baumannii—an emerging opportunistic pathogen. Virulence. 2012;3:1–8.CrossRef
19.
go back to reference Iwashkiw JA, Seper A, Weber BS, Scott NE, Vinogradov CS, Reiz B. CordwellSJ, Whittal R, Schild S, Feldman MF. Identification of a general O-linked Protein Glycosylation System in Acinetobacter baumannii and its role in virulence and biolfilm formation. PLoS Pathog. 2012;8:e1002758.PubMedCentralPubMedCrossRef Iwashkiw JA, Seper A, Weber BS, Scott NE, Vinogradov CS, Reiz B. CordwellSJ, Whittal R, Schild S, Feldman MF. Identification of a general O-linked Protein Glycosylation System in Acinetobacter baumannii and its role in virulence and biolfilm formation. PLoS Pathog. 2012;8:e1002758.PubMedCentralPubMedCrossRef
20.
go back to reference Lee NY, Chang TC, Wu CJ, Chang CM, Lee HC, Chen PL, Lee CC, Ko NY, Ko WC. Clinical manifestations, antimicrobial therapy, and prognostic factors of monocrobial Acinetobacter baumannii complex bacteremia. J Infect. 2010;61:219–27.PubMedCrossRef Lee NY, Chang TC, Wu CJ, Chang CM, Lee HC, Chen PL, Lee CC, Ko NY, Ko WC. Clinical manifestations, antimicrobial therapy, and prognostic factors of monocrobial Acinetobacter baumannii complex bacteremia. J Infect. 2010;61:219–27.PubMedCrossRef
Metadata
Title
Trauma is associated with a better prognosis in intensive care patients with Acinetobacter infections
Authors
A. C. Tonacio
M. S. Oliveira
L. M. S. Malbouisson
A. S. Levin
Publication date
01-02-2014
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 1/2014
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-013-0523-y

Other articles of this Issue 1/2014

Infection 1/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.